Company Filing History:
Years Active: 2024
Title: Jong Ouk Baek: Innovator in Quinazoline Compounds
Introduction
Jong Ouk Baek is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of quinazoline compounds. His work has led to advancements that may benefit various therapeutic applications.
Latest Patents
Jong Ouk Baek holds a patent for "Crystalline forms of a quinazoline compound and its hydrochloride salts." This patent document pertains to the crystalline forms of a specific quinazoline compound and its hydrochloride salts. More specifically, it details a preparation method for the crystalline forms of 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one and its hydrochloride salts. This innovation showcases his expertise in chemical formulations and their potential applications in medicine.
Career Highlights
Throughout his career, Jong Ouk Baek has worked with prominent companies in the pharmaceutical industry. He has been associated with Hanmi Pharmaceutical Co., Ltd. and Spectrum Pharmaceuticals, Inc. His experience in these organizations has contributed to his development as a leading inventor in his field.
Collaborations
Jong Ouk Baek has collaborated with several professionals in his field, including Hee Cheol Kim and Tae Hee Ha. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in pharmaceutical sciences.
Conclusion
Jong Ouk Baek is a distinguished inventor whose work in quinazoline compounds has the potential to impact the pharmaceutical industry significantly. His patent and collaborations reflect his commitment to advancing medical science through innovation.